05:06 PM EDT, 05/20/2024 (MT Newswires) -- Rishi Gupta, 10% Owner, Director, on May 16, 2024, sold 1,033,300 shares in Enliven Therapeutics ( ELVN ) for $22,877,262. Following the Form 4 filing with the SEC, Gupta has control over a total of 7,663,349 shares of the company, with 7,663,349 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1672619/000094787124000501/xslF345X03/ownership.xml